EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study

Marc R Sapoval, Shivank Bhatia, Carole Déan, Antonio Rampoldi, Francisco César Carnevale, Clare Bent, Charles R Tapping, Simone Bongiovanni, Jeremy Taylor, Jayson S Brower, Michael Rush, Justin P McWilliams und 2 weitere

CardioVascular and Interventional Radiology · 2024-11 · 47 (11) · 1515-1524

DOI: 10.1007/s00270-024-03802-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 04.09.2024. Verfasst von Marc R Sapoval und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Oncological Interventional Radiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leb…. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Prostate, Prostatic Hyperplasia, Quality of Life. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merit Medical Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe clinical outcomes among patients with benign prostatic hyperplasia (BPH) 24 months following prostatic artery embolization (PAE). Materials and Methods This was an international, multicenter, prospective trial of males with BPH with lower urinary tract symptoms (LUTS) or acute urinary retention (AUR) treated with PAE. The primary outcome was the 12 month change in the International Prostate Symptom Score (IPSS) for patients referred for bothersome LUTS, or urinary catheter independence for patients treated for AUR. Secondary outcome measures included changes in IPSS at 3 and 24 months, changes in quality of life (QoL), changes in the Sexual Health Inventory for Men (SHIM) questionnaire, technical success rate, and adverse events (AEs). Data were summarized using descriptive statistics.

Results

Four hundred seventy-eight consecutive patients underwent PAE (bothersome LUTS: N = 405; AUR: N = 73), mean age was 70 years. For patients treated for bothersome LUTS, mean total IPSS at baseline was 21.8 and decreased to 9.3, 10.6, and 11.2 at 3, 12, and 24 months following PAE, respectively (all p < 0.001); QoL at baseline was 4.7 and decreased to 2.0, 2.1, and 2.3 at 3, 12, and 24 months, respectively (all p < 0.001). The mean SHIM score at baseline and 12 months following PAE was 13.8 and 13.9, respectively. Of the 73 patients treated for AUR, 48 (65.8%) had their indwelling catheter removed within 3 months of PAE and remained catheter free at 24 months. Fifty-five patients (11.5%) experienced ≥ 1 AE and 10 (2.1%) experienced a serious AE.

Conclusion

PAE is a safe and effective treatment for symptomatic BPH and LUTS. Level of Evidence Level 3 Trial registration ClinicalTrials.gov NCT03527589. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolization, TherapeuticProstateProstatic HyperplasiaQuality of LifeAgedAged, 80 and overHumansMaleMiddle AgedLower Urinary Tract SymptomsProspective StudiesSurveys and QuestionnairesTreatment OutcomeUrinary RetentionRegistries

Stichwörter der Autor:innen

Acute urinary retentionBenign prostatic hyperplasiaEmbosphere® MicrospheresInternational Prostate Symptom Score (IPSS)Lower urinary tract symptomsProstatic artery embolizationQuality of lifeSexual Health Inventory for Men (SHIM)

Autor:innen und Institutionen

  • Department of Vascular and Oncological Interventional Radiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015, Paris, France. marc.sapoval2@aphp.fr.
  • Department of Interventional Radiology, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Department of Vascular and Oncological Interventional Radiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015, Paris, France.
  • Department of Interventional Radiology, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Department of Radiology, Instituto de Radiologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
  • Department of Interventional Radiology, Royal Bournemouth and Christchurch Hospital, Bournemouth, UK.

Förderung

  • Merit Medical Systems

Zitieren

APA

Sapoval, M. R., Bhatia, S., Déan, C., Rampoldi, A., Carnevale, F. C., Bent, C., Tapping, C. R., Bongiovanni, S., Taylor, J., Brower, J. S., Rush, M., McWilliams, J. P., Little, M. W., & PROstate Study Investigators (2024). Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study. CardioVascular and Interventional Radiology, 47(11), 1515-1524. https://doi.org/10.1007/s00270-024-03802-0

Vancouver

Sapoval MR, Bhatia S, Déan C, Rampoldi A, Carnevale FC, Bent C, et al. Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study. CardioVascular and Interventional Radiology. 2024;47(11):1515-1524. doi:10.1007/s00270-024-03802-0

BibTeX
@article{Sapoval2024,
  author = {Sapoval, Marc R and Bhatia, Shivank and Déan, Carole and Rampoldi, Antonio and Carnevale, Francisco César and Bent, Clare and Tapping, Charles R and Bongiovanni, Simone and Taylor, Jeremy and Brower, Jayson S and Rush, Michael and McWilliams, Justin P and Little, Mark W and PROstate Study Investigators, PROstate Study Investigators},
  title = {Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  volume = {47},
  number = {11},
  pages = {1515--1524},
  doi = {10.1007/s00270-024-03802-0}
}
Kostenlos starten →